Abstract: An unmanned aerial system includes a remote controller device and an unmanned aerial vehicle. A user input on the remote controller device indicates a flight command requested by a user. The remote controller device determines a current position and/or orientation of the remote controller device in response to the flight command from the user. The current position and/or orientation is sent to the vehicle. The vehicle responsively determines a desired orientation of the unmanned aerial vehicle as a function of the current position and/or orientation of the remote controller device and operates a lift mechanism to execute a flight operation based on the desired orientation of the unmanned aerial vehicle and the current position of the remote controller device.

Abstract: An ultra high molecular weight polyethylene (UHMWPE) membrane has at least one nanoporous UHMWPE film, where each of the nanoporous UHMWPE film is biaxial oriented with a thickness of 0.1 to 12 ?m and pores that exclude particles in excess of 10 nm with a total porosity of 65 to 75 percent. The nanoporous UHMWPE film can be coated or laminated by a hydrophilic polymer to form a Janus membrane and can be made with a multilayer composite structure. The UHMWPE membrane can be used in a device for molecular distillation (MD), reverse osmosis (RO), or forward osmosis (FO).

Abstract: A request for a contact center agent interaction is received from a user device associated with a first user. The user device is connected to a virtual waiting room that includes waiting users of a contact center queue. The waiting users include a second user. from the second user A favorable indication of the first user is received from the second user. A position of the first user in the contact center queue is modified based on the favorable indication. Responsive to an indication to activate a private session between the user device and an agent device associated with a contact center agent, the first user is removed from the virtual waiting room.

Abstract: With respect to a package delivery system configured to optimize efficiencies associated with package delivery, a server computing device may monitor locations and conditions associated with a fleet of vehicles. A vehicle including a first delivery person may be dispatched with packages for delivery. The server computing device may provide updated delivery routes based on traffic and/or other conditions in the environment. At the completion of a work shift associated with the first delivery person, the vehicle may be parked at a location proximate the delivery route. The server computing device may dispatch a second delivery person to the location. Based on an indication that the second delivery person is proximate the vehicle, the server computing device may cause a user interface to surface on a computing device of the second delivery person, enabling the second delivery person to unlock the vehicle and continue delivering the packages.

Abstract: A micro-displacement amplifying apparatus comprises two sets of asymmetrical amplifying structures; each set of asymmetrical amplifying structure comprises a plurality of asymmetrical amplifying units connected in series by flexible hinges; the asymmetrical amplifying unit is used for amplifying a micro-displacement; the two sets of asymmetrical amplifying structures are in opposite positions and overlap with each other; the input end and output end are coupled to the asymmetrical amplifying unit by a flexible hinge, respectively; the input end is used for inputting the micro-displacement to the asymmetrical amplifying unit, and the output end is used for outputting the amplified displacement; the two contacting input ends are fixed and coupled to each other, and the two contacting output ends are fixed and coupled to each other. The present disclosure further discloses an amplification method of the micro-displacement amplifying apparatus.

Abstract: A method of preparing ferric phosphate from iron-containing waste, including: step a) providing a ferric chloride-containing mixture solution obtained from acidolysis of iron-containing waste; step b) adjusting pH of the ferric chloride-containing mixture solution to satisfy 0<pH?2 and Fe3+ concentration to 10-80 g/L with an alkaline compound and water, to obtain an iron source solution; step c) mixing and reacting the iron source solution obtained from the step b) with a solution of calcium dihydrogen phosphate in a molar ratio of P to Fe of 1 : 1-1.8, to obtain a slurry with a pH of 0.2-2; and step d) performing aging and crystal transformation on the slurry, to obtain ferric phosphate. A battery-grade ferric phosphate with high purity and good product quality can be obtained without the need for deep purification of raw materials.

Abstract: Embodiments herein describe a beacon that is used to verify a location of a user and provide access to a secure location (e.g., a locked building). The beacon includes a radio frequency reader which communicates with a tag (e.g., an NFC or RFID tag) disposed on a same surface as the beacon. For example, the beacon may cover the tag on the surface (e.g., a wall next to a locked door or access point into the secure location). The reader in the beacon can periodically perform a read cycle to identify the presence of the tag to ensure the beacon has not been removed. If during one or more cycles the reader does not detect the tag, the beacon can deactivate the beacon and no longer transmit the location verification code.

Abstract: A folding shed may include a roof portion, a lateral portion and a bottom portion, said lateral portions forming two lateral sides of the shed that connects the roof portion and the bottom portion. Each roof portion, lateral portion and bottom portion includes a plurality of connecting units and hinge units, and each hinge unit is configured to pivotally connect with a longitudinal side of one connecting unit and pivotally connect with the other longitudinal side of an adjacent connecting unit. At least one hinge unit is configured to pivotally connect a corresponding connecting unit in the roof portion and a corresponding connecting unit in the lateral portion, and at least another hinge unit is configured to pivotally connect a corresponding connecting unit in the lateral portion and a corresponding connecting unit in the bottom portion.

Abstract: The present invention provides PRMT5 inhibitors of Formula (I), wherein R1 is a non-hydrogen monovalent group; W is a direct bond or —NH—; T, U, and V are independently of each other selected from C and N; R2 is H or a halo; m is 1 or 2; X is a carbon, a nitrogen, or an oxygen; Y is C or N; Z is a direct bond or a carbon; R3 is H, a non-hydrogen monovalent group, an oxo group, a bivalent spiro ring-forming group, or a bivalent bridge-forming group; n is 1 or 2; and Formula (II) stands for a single bond or a double bond. Pharmaceutical products comprising the PRMT5 inhibitors and use thereof in treating proliferative disorders such as cancer, metabolic disorders, blood disorders, autoimmune diseases, and inflammatory diseases are also provided.

Abstract: Disclosed is a macrocyclic kinase inhibitor, wherein the compound, or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof is as shown in formula I. Experiments show that the new compound as shown in formula I disclosed in the present invention exhibits an excellent TRK inhibitory activity, has a significant inhibitory effect on TRKA-mutant cell growth, and exhibits an excellent inhibitory effect on in vivo tumor growth, thus providing a new choice for the clinical treatment of diseases associated with abnormal TRK activity.

Abstract: Embodiments of the present disclosure relate to a method, an electronic device, and a computer program product for application migration. The method includes determining an application used by a terminal device if it is determined that the terminal device moves from a first cell provided by a first network device to a second cell provided by a second network device. The method also includes determining a migration strategy for the application, the migration strategy describing the migration of components of the application in a predetermined scenario corresponding to the application. The method also includes determining migration information of components in an initial edge node associated with the first network device to a target edge node associated with the second network device based on the migration strategy, the migration information at least indicating whether the components in the initial edge node are to be migrated to the target edge node.

Abstract: Materials and methods are provided for making plants (e.g., Nicotiana varieties) that are suitable for producing therapeutic polypeptides suitable for administration to humans and animals, particularly by making TAL effector endonuclease-induced mutations in genes encoding xylosyltransferases and fucosyltransferases.

Abstract: Techniques are disclosed for scheduling artificial intelligence model partitions for execution in an information processing system. For example, a method comprises the following steps. An intermediate representation of an artificial intelligence model is obtained. A reversed computation graph corresponding to a computation graph generated based on the intermediate representation is obtained. Nodes in the reversed computation graph represent functions related to the artificial intelligence model, and one or more directed edges in the reversed computation graph represent one or more dependencies between the functions. The reversed computation graph is partitioned into sequential partitions, such that the partitions are executed sequentially and functions corresponding to nodes in each partition are executed in parallel.

Abstract: Provided is a novel coronavirus vaccine using replication-deficient human type 5 adenovirus as a vector. The vaccine takes the replication-deficient human type 5 adenovirus that is lack of E1 and E3 in a combined mode as a vector, and HEK293 cells that integrate adenovirus E1 genes serve as a packaging cell line, and protective antigenic genes carried are optimized COVID-19 (SARS-CoV-2) S protein genes (Ad5-nCoV). The vaccine has good immunogenicity in both mouse and guinea pig models and can induce the body to produce a strong cellular and humoral immune responses in a short time. Research on the protective effect of hACE2 transgenic mice shows that 14 days after a single Ad5-nCoV immunization, the viral load in lung tissues can be significantly reduced. It shows that the vaccine has a good immune protection effect against COVID-19.

Abstract: Materials and methods are provided for making plants (e.g., Nicotiana varieties) that are suitable for producing therapeutic polypeptides suitable for administration to humans and animals, particularly by making TAL effector endonuclease-induced mutations in genes encoding xylosyltransferases and fucosyltransferases.

Abstract: A sentiment-based score is determined for a contact center engagement between a first contact center service operator and a contact center user. The sentiment-based score is indicated within a graphical user interface displaying information associated with multiple contact center engagements at a device of a second contact center service operator. Based on a request to participate in the contact center engagement received from the device of the second contact center service operator via the graphical user interface, information associated with the contact center engagement is transmitted to the device of the second contact center service operator, and a contact center session involving a device of the contact center user and the device of the second contact center service operator is established.

Abstract: Disclosed are various embodiments for anonymously validating the identities of multiple parties participating a transaction. In one embodiment, a system is configured to determine a location of the system is within a proximity threshold of a location and transmit an arrival indication to a remote computing device. The system is also configured to receive an encryption key from the remote computing device and detect a client device located at the location. The encryption key can be transmitted to the client device for validation that the location of the computing device is the location.

Abstract: Consistency metadata, including a parameter for a pseudo-random number source, are determined for training-and-evaluation iterations of a machine learning model. Using the metadata, a first training set comprising records of at least a first chunk is identified from a plurality of chunks of a data set. The first training set is used to train a machine learning model during a first training-and-evaluation iteration. A first test set comprising records of at least a second chunk is identified using the metadata, and is used to evaluate the model during the first training-and-evaluation iteration.

Abstract: Semiconductor packages and package assemblies having active dies and external die mounts on a silicon wafer, and methods of fabricating such semiconductor packages and package assemblies, are described. In an example, a semiconductor package assembly includes a semiconductor package having an active die attached to a silicon wafer by a first solder bump. A second solder bump is on the silicon wafer laterally outward from the active die to provide a mount for an external die. An epoxy layer may surround the active die and cover the silicon wafer. A hole may extend through the epoxy layer above the second solder bump to expose the second solder bump through the hole. Accordingly, an external memory die can be connected directly to the second solder bump on the silicon wafer through the hole.

Abstract: Provided is an anti-PD-L1 antigen binding protein, capable of binding to primate-derived PD-L1 with a KD value of 1×10?8 M or less. The antigen binding protein can block the binding of PD-1 and CD80 to PD-L1, stimulate the secretion of cytokines in immune cells, and can inhibit tumor growth and/or tumor cell proliferation. Also provided is a fusion protein, comprising human TGFBRII or a fragment thereof and the antigen binding protein. Also provided is an application of the antigen binding protein and/or the fusion protein in the prevention and treatment of tumors or cancers.